218 related articles for article (PubMed ID: 20811628)
1. Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis.
Hov JR; Keitel V; Laerdahl JK; Spomer L; Ellinghaus E; ElSharawy A; Melum E; Boberg KM; Manke T; Balschun T; Schramm C; Bergquist A; Weismüller T; Gotthardt D; Rust C; Henckaerts L; Onnie CM; Weersma RK; Sterneck M; Teufel A; Runz H; Stiehl A; Ponsioen CY; Wijmenga C; Vatn MH; ; Stokkers PC; Vermeire S; Mathew CG; Lie BA; Beuers U; Manns MP; Schreiber S; Schrumpf E; Häussinger D; Franke A; Karlsen TH
PLoS One; 2010 Aug; 5(8):e12403. PubMed ID: 20811628
[TBL] [Abstract][Full Text] [Related]
2. TGR5 sequence variation in primary sclerosing cholangitis.
Hov JR; Keitel V; Schrumpf E; Häussinger D; Karlsen TH
Dig Dis; 2011; 29(1):78-84. PubMed ID: 21691110
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis.
Reich M; Spomer L; Klindt C; Fuchs K; Stindt J; Deutschmann K; Höhne J; Liaskou E; Hov JR; Karlsen TH; Beuers U; Verheij J; Ferreira-Gonzalez S; Hirschfield G; Forbes SJ; Schramm C; Esposito I; Nierhoff D; Fickert P; Fuchs CD; Trauner M; García-Beccaria M; Gabernet G; Nahnsen S; Mallm JP; Vogel M; Schoonjans K; Lautwein T; Köhrer K; Häussinger D; Luedde T; Heikenwalder M; Keitel V
J Hepatol; 2021 Sep; 75(3):634-646. PubMed ID: 33872692
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4.
Ellinghaus D; Folseraas T; Holm K; Ellinghaus E; Melum E; Balschun T; Laerdahl JK; Shiryaev A; Gotthardt DN; Weismüller TJ; Schramm C; Wittig M; Bergquist A; Björnsson E; Marschall HU; Vatn M; Teufel A; Rust C; Gieger C; Wichmann HE; Runz H; Sterneck M; Rupp C; Braun F; Weersma RK; Wijmenga C; Ponsioen CY; Mathew CG; Rutgeerts P; Vermeire S; Schrumpf E; Hov JR; Manns MP; Boberg KM; Schreiber S; Franke A; Karlsen TH
Hepatology; 2013 Sep; 58(3):1074-83. PubMed ID: 22821403
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide association analysis in primary sclerosing cholangitis.
Karlsen TH; Franke A; Melum E; Kaser A; Hov JR; Balschun T; Lie BA; Bergquist A; Schramm C; Weismüller TJ; Gotthardt D; Rust C; Philipp EE; Fritz T; Henckaerts L; Weersma RK; Stokkers P; Ponsioen CY; Wijmenga C; Sterneck M; Nothnagel M; Hampe J; Teufel A; Runz H; Rosenstiel P; Stiehl A; Vermeire S; Beuers U; Manns MP; Schrumpf E; Boberg KM; Schreiber S
Gastroenterology; 2010 Mar; 138(3):1102-11. PubMed ID: 19944697
[TBL] [Abstract][Full Text] [Related]
6. A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients.
Paziewska A; Habior A; Rogowska A; Zych W; Goryca K; Karczmarski J; Dabrowska M; Ambrozkiewicz F; Walewska-Zielecka B; Krawczyk M; Cichoz-Lach H; Milkiewicz P; Kowalik A; Mucha K; Raczynska J; Musialik J; Boryczka G; Wasilewicz M; Ciecko-Michalska I; Ferenc M; Janiak M; Kanikowska A; Stankiewicz R; Hartleb M; Mach T; Grzymislawski M; Raszeja-Wyszomirska J; Wunsch E; Bobinski T; Mikula M; Ostrowski J
BMC Med Genomics; 2017 Jan; 10(1):2. PubMed ID: 28056976
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis.
Juran BD; Atkinson EJ; Schlicht EM; Larson JJ; Ellinghaus D; Franke A; Lazaridis KN
Liver Int; 2011 Jul; 31(6):785-91. PubMed ID: 21134112
[TBL] [Abstract][Full Text] [Related]
8. TGR5: pathogenetic role and/or therapeutic target in fibrosing cholangitis?
Keitel V; Reich M; Häussinger D
Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):218-25. PubMed ID: 25138774
[TBL] [Abstract][Full Text] [Related]
9. Role of miR-506 in ulcerative colitis associated with primary sclerosing cholangitis.
Kempinska-Podhorodecka A; Adamowicz M; Ostrycharz E; Chmielarz M; Wójcicki M; Milkiewicz P; Milkiewicz M
Sci Rep; 2021 May; 11(1):10134. PubMed ID: 33980925
[TBL] [Abstract][Full Text] [Related]
10. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.
Karlsen TH; Boberg KM; Vatn M; Bergquist A; Hampe J; Schrumpf E; Thorsby E; Schreiber S; Lie BA;
Genes Immun; 2007 Apr; 8(3):275-8. PubMed ID: 17301827
[TBL] [Abstract][Full Text] [Related]
11. Whole Exome Sequencing Identifies Two Novel Mutations in a Patient with UC Associated with PSC and SSA.
Wu D; Chen D; Shi W; Liu W; Zhou W; Qian J
Can J Gastroenterol Hepatol; 2021; 2021():9936932. PubMed ID: 34545326
[TBL] [Abstract][Full Text] [Related]
12. Bile acid receptors in the biliary tree: TGR5 in physiology and disease.
Deutschmann K; Reich M; Klindt C; Dröge C; Spomer L; Häussinger D; Keitel V
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1319-1325. PubMed ID: 28844960
[TBL] [Abstract][Full Text] [Related]
13. Oncomir MicroRNA-346 Is Upregulated in Colons of Patients With Primary Sclerosing Cholangitis.
Kempinska-Podhorodecka A; Blatkiewicz M; Wunsch E; Krupa L; Gutkowski K; Milkiewicz P; Milkiewicz M
Clin Transl Gastroenterol; 2020 Jan; 11(1):e00112. PubMed ID: 31972611
[TBL] [Abstract][Full Text] [Related]
14. Analysis of IL2/IL21 gene variants in cholestatic liver diseases reveals an association with primary sclerosing cholangitis.
Stallhofer J; Denk GU; Glas J; Laubender RP; Göke B; Rust C; Brand S; Pusl T
Digestion; 2011; 84(1):29-35. PubMed ID: 21304239
[TBL] [Abstract][Full Text] [Related]
15. Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis.
Vessby J; Lampinen M; Åberg M; Rorsman F; Siegbahn A; Wanders A; Carlson M
Ups J Med Sci; 2019 Nov; 124(4):238-245. PubMed ID: 31774347
[No Abstract] [Full Text] [Related]
16. Downregulated eosinophil activity in ulcerative colitis with concomitant primary sclerosing cholangitis.
Lampinen M; Fredricsson A; Vessby J; Martinez JF; Wanders A; Rorsman F; Carlson M
J Leukoc Biol; 2018 Jul; 104(1):173-183. PubMed ID: 29603385
[TBL] [Abstract][Full Text] [Related]
17. Modulation of Mismatch Repair and the SOCS1/p53 Axis by microRNA-155 in the Colon of Patients with Primary Sclerosing Cholangitis.
Adamowicz M; Stukan I; Milkiewicz P; Bialek A; Milkiewicz M; Kempinska-Podhorodecka A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563301
[TBL] [Abstract][Full Text] [Related]
18. High Serum sCD40 and a Distinct Colonic T Cell Profile in Ulcerative Colitis Associated With Primary Sclerosing Cholangitis.
Lampinen M; Vessby J; Fredricsson A; Wanders A; Rorsman F; Carlson M
J Crohns Colitis; 2019 Mar; 13(3):341-350. PubMed ID: 30383225
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis.
Kevans D; Tyler AD; Holm K; Jørgensen KK; Vatn MH; Karlsen TH; Kaplan GG; Eksteen B; Gevers D; Hov JR; Silverberg MS
J Crohns Colitis; 2016 Mar; 10(3):330-7. PubMed ID: 26526357
[TBL] [Abstract][Full Text] [Related]
20. Epithelial markers of colorectal carcinogenesis in ulcerative colitis and primary sclerosing cholangitis.
Wohl P; Hucl T; Drastich P; Kamenar D; Spicak J; Honsova E; Sticova E; Lodererova A; Matous J; Hill M; Wohl P; Kucera M
World J Gastroenterol; 2013; 19(14):2234-41. PubMed ID: 23599650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
